Cargando…
Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty
Cancer ranks as one of the deadliest diseases worldwide. The high mortality rate associated with cancer is partially due to the lack of reliable early detection methods and/or inaccurate diagnostic tools such as certain protein biomarkers. Cell-free nucleic acids (cfNA) such as circulating long nonc...
Autores principales: | Badowski, Cedric, He, Bing, Garmire, Lana X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213432/ https://www.ncbi.nlm.nih.gov/pubmed/35729321 http://dx.doi.org/10.1038/s41698-022-00283-7 |
Ejemplares similares
-
LncRNAs, MALAT1 and lnc-DC as potential biomarkers for multiple sclerosis diagnosis
por: Shaker, Olfat G., et al.
Publicado: (2019) -
LncRNAs serve as novel biomarkers for diagnosis and prognosis of childhood ALL
por: Huang, Xuanmei, et al.
Publicado: (2021) -
LncRNAs: Novel Biomarkers for Pancreatic Cancer
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021) -
LncRNAs and EGFRvIII sequestered in TEPs enable blood-based NSCLC diagnosis
por: Luo, Chang-Liang, et al.
Publicado: (2018) -
Decoding LncRNAs
por: Borkiewicz, Lidia, et al.
Publicado: (2021)